- Water for Injection is the highest-purity pharmaceutical water grade, required wherever water contacts a sterile injectable or biologic product, and it drives roughly 79% of pharmaceutical water market revenue (Towards Healthcare, 2025).
- Roughly 85% of installed WFI systems still use multi-effect or vapor compression distillation, though the current USP monograph also permits validated membrane-based (RO) production (Towards Healthcare, 2025).
- WFI’s defining feature isn’t just purity level, it’s the specific endotoxin control (≤0.25 EU/mL) that non-injectable pharmaceutical water grades don’t need to guarantee.
What Is Water for Injection (WFI)?
Water for Injection is pharmaceutical water purified and controlled to a standard suitable for use in or on sterile injectable and biologic products, the strictest grade in the pharmaceutical water hierarchy. What sets WFI apart from other high-purity grades isn’t just tighter numeric limits, it’s the specific endotoxin control built into its production and monitoring that non-injectable water grades simply don’t need to guarantee.
What Standards and Limits Apply to WFI?
WFI meets the same conductivity and TOC limits as Purified Water (1.3 µS/cm Stage 1 conductivity, USP <643> TOC testing), but adds a defined endotoxin limit, typically ≤0.25 EU/mL, and stricter microbial limits reflecting its sterile-adjacent use. USP General Chapter <1231> governs the design, validation, and monitoring life cycle for WFI systems, the same framework applied to other pharmaceutical water grades but with WFI-specific rigor around endotoxin control.
How Is WFI Produced?
Roughly 85% of installed WFI systems still rely on multi-effect distillation or vapor compression distillation, technologies with decades of validated performance history that regulators are comfortable with (Towards Healthcare, 2025). Distillation reliably achieves the endotoxin control WFI requires because the phase change (liquid to vapor and back) leaves non-volatile endotoxins behind.
The current USP monograph also permits validated non-distillation methods, primarily membrane-based systems combining RO, UF, and additional polishing, giving facilities a lower-energy alternative where validation can demonstrate equivalent endotoxin control. Adoption of membrane-based WFI production is growing but hasn’t displaced distillation as the dominant method.
What Is WFI Used For?
WFI is required for formulating sterile injectable drugs and biologics, for final rinse of equipment and containers before aseptic filling, and for any process step where the water becomes part of, or directly contacts, a sterile product. Once produced, WFI needs to be stored and distributed under conditions, typically hot storage above 80°C or continuously recirculating cold storage, that prevent microbial regrowth between production and point of use.
Frequently Asked Questions
What is the difference between WFI and purified water?
WFI adds a defined endotoxin limit (typically 0.25 EU/mL) and stricter microbial control on top of the conductivity and TOC limits both grades share, reflecting WFI’s use in sterile injectable and biologic production.
Is distillation required to produce WFI?
Not anymore. While roughly 85 percent of installed systems still use multi-effect or vapor compression distillation, the current USP monograph also permits validated membrane-based production methods.
How is WFI stored to prevent contamination?
WFI storage systems typically maintain hot storage above 80 degrees Celsius or continuously recirculating cold storage loops, both designed to prevent the microbial regrowth that stagnant water at ambient temperature would allow.
SKE & Eagle WFI Systems
SKE & Eagle designs WFI systems and multi-effect distillation units built to USP <1231> validation requirements, with both distillation and membrane-based production options.